Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 8, 2004, Pages 442-448

  Persky, A M ^a   Ng, C ^a   Song, M H ^a   Lancaster, M E ^b   Balderson, D E ^b   Paulik, M A ^b   Brouwer, K L R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Infrared thermography; Therapeutic index; Weight loss

Indexed keywords

EPHEDRINE; FATTY ACID; GLUCOSE; GLYCEROL; PLACEBO; SIBUTRAMINE; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; FEMALE; HEART RATE; HUMAN; HUNGER; MALE; METABOLIC RATE; OBESITY; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; VOLUNTEER; WEIGHT REDUCTION;

EID: 4444310511     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42442     Document Type: Article

References (22)

1. Astrup A, Toubro S, Cannon S, Hein P. Madsen, J 1991 Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Metabolism 40: 323-329
2. Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ et al 1992 The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism 41. 686-688
3. Astrup A, Toubro S, 1993 Thermogenic, metabolic and cardiovascular responses to ephedrine and caffeine in man. Int J Obes Relat Metab Disord 17 (Suppl 1): S41-43
4. Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B et al 2001 Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. Eur J Clin Pharmacol 57: 447-455
5. Doucet E, St-Pierre S, Almeras N, Mauriege P. Despres JP, Richard D et al 2000 Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention Study. J Clin Endocrinol Metab 85: 4231-4237
6. Doucet E, St-Pierre S, Almeras N, Imbeault P, Mauriege P, Pascot A et al 2002 Reduction of visceral adipose tissue during weight loss. Eur. J Clin Nutr 56. 297-304
7. Farrigan C, Pang K 2002 Obesity market overview. Nat Rev Drug Discov 1. 257-258
8. Haller CA, Jacob P, Benowitz NL 2002 Pharmacology of ephedra alkaloids and caffeine after single-close dietary Supplement use. Clin Pharmacol Ther 71. 421-432
9. Hansen DLl, Toubro S, Stock MJ, Macdonald IA, Astrup A 1998 Thermogenic effects of sibutramine in humans. Am J Clin Nutr 68: 1180-1186
10. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A 1999 The effect of sibutramine oil energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 23: 1016-1024
11. Horton TJ, Geissler CA 1991 Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women. Int J Obes 15: 359-366
12. Krejs GJ 2002 Metabolic benefits associated with sibutramine therapy. Int J Obes Relat Metab Disord 26 (Suppl 4). S34-37
13. Narkiewics K 2002 Sibutramine and its cardiovascular profile. Int J Obes Relat Metab Disord 20 (Suppl 4). S38-41
14. Nelson HS, Black, JW, Branch LB, Pfuetze B, Spaulding H, Summers R et al 1975 Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. J Allergy Clin Immunol 55. 299-309
15. Persky AM, Berry NS, Pollack GM, Brouwer KLR 2004 Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol 57. 552-562
16. Satomura S, Yokota I, Tatara K, Naito E, Ito M, Kuroda Y 2001 Paradoxical weight loss with extra energy expenditure at brown adipose tissue in adolescent patients with Duchenne muscular dystrophy. Metabolism 50: 1181-1185
17. Schiffelers SL, Saris WH. Van Baak MA 2001 The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men. Int J Obes Relat Metab Disord 25. 33-38
18. Seagle HM, Bessesen DH, Hill JO 1998 Effects of sibutramine on resting metabolic rate and weight loss in overweight women. Obes Res 6. 115-121
19. Shannon JR, Gottesdiener K, Jordan.J, Chen K, Flattery S, Larson PJ et al 1999 Acute effect of ephedrine on 24-h energy balance. Clin Sci Lond 96: 483-491
20. Sharma AM 2001 Sibutramine in overweight/obese hypertensive patients. Int J Obes Relat Metab Disord 25 (Suppl 4). S20-23
21. Starling RD, Liu X, Sullivan DH 2001 Influence of sibutramine on energy expenditure in African American women. Obes Res 9: 251-256
22. WHO 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO, Geneva